BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28028610)

  • 1. Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study.
    Han M; Jung YS; Kim WH; Cheon JH; Park S
    J Gastroenterol; 2017 Aug; 52(8):920-928. PubMed ID: 28028610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Jung YS; Han M; Kim WH; Park S; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease.
    Jung YS; Yoon JY; Hong SP; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2012 Jun; 18(6):1064-71. PubMed ID: 21793128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Risk in Patients with Intestinal Behçet's Disease: A Nationwide Population-Based Study.
    Han M; Jung YS; Kim WH; Cheon JH; Park S
    Gut Liver; 2018 Jul; 12(4):433-439. PubMed ID: 29429154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, prevalence, and mortality of Adamantiades-Behçet's disease in Korea: a nationwide, population-based study (2006-2015).
    Lee YB; Lee SY; Choi JY; Lee JH; Chae HS; Kim JW; Han KD; Park YG; Yu DS
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):999-1003. PubMed ID: 28940547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant Decline in the Incidence of Behçet's Disease in South Korea: A Nationwide Population-Based Study (2004-2017).
    Jun JB; Kim HJ; Kazmi SZ; Kang T; Kim KB; Kang MJ; Ahn HS
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1689-1696. PubMed ID: 32770715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors and Outcomes of Emergency Room Visits in Intestinal Behçet's Disease.
    Park J; Cheon JH; Park Y; Park SJ; Kim TI; Kim WH
    Digestion; 2017 Nov; 96(4):231-238. PubMed ID: 29131059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes of intestinal Behçet's disease: A 30-year cohort study at a tertiary hospital in South Korea.
    Park J; Park SJ; Park JJ; Kim TI; Cheon JH
    J Gastroenterol Hepatol; 2023 Mar; 38(3):386-392. PubMed ID: 36346041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.
    Park J; Cheon JH; Park YE; Lee YJ; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
    Int J Colorectal Dis; 2017 May; 32(5):745-751. PubMed ID: 27924367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
    Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS
    Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated treatment strategies for intestinal Behçet's disease.
    Park YE; Cheon JH
    Korean J Intern Med; 2018 Jan; 33(1):1-19. PubMed ID: 29207867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of Behçet's disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015.
    Kim JN; Kwak SG; Choe JY; Kim SK
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):38-42. PubMed ID: 28134076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome predictors for intestinal Behçet's disease.
    Park JJ; Kim WH; Cheon JH
    Yonsei Med J; 2013 Sep; 54(5):1084-90. PubMed ID: 23918555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes and Predictors of Sustained Response in Patients with Intestinal Behcet's Disease Treated with Infliximab.
    Zou J; Ji DN; Cai JF; Guan JL; Bao ZJ
    Dig Dis Sci; 2017 Feb; 62(2):441-447. PubMed ID: 28044230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes of Crohn's disease and intestinal Behcet's disease.
    Jung YS; Cheon JH; Park SJ; Hong SP; Kim TI; Kim WH
    Inflamm Bowel Dis; 2013 Jan; 19(1):99-105. PubMed ID: 22508364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between smoking and Behçet's disease: a nationwide population-based study in Korea.
    Lee YB; Lee JH; Lee SY; Lee JH; Yu DS; Han KD; Park YG
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2114-2122. PubMed ID: 31121063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behçet's disease.
    Arimoto J; Endo H; Kato T; Umezawa S; Fuyuki A; Uchiyama S; Higurashi T; Ohkubo H; Nonaka T; Takeno M; Ishigatsubo Y; Sakai E; Matsuhashi N; Nakajima A
    Dig Endosc; 2016 Mar; 28(2):179-85. PubMed ID: 26459917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk in Korean patients with Behçet's disease: A nationwide population-based study.
    Jung YS; Han M; Kim DY; Cheon JH; Park S
    PLoS One; 2017; 12(12):e0190182. PubMed ID: 29287101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcomes and risk factors of early readmission in patients with intestinal Behçet's disease.
    Park YE; Cheon JH; Park Y; Park SJ; Kim TI; Kim WH
    Clin Rheumatol; 2018 Jul; 37(7):1913-1920. PubMed ID: 29116542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.